Radiation Exposure of the Embryo/Foetus and the Newborn Child

Chapter

Abstract

This chapter addresses risks and radiation protection aspects in medical exposures when embryo/foetus or infants are involved, following exposures of pregnant women or breastfeeding women, including patients or workers.

The effects of radiation in prenatal exposures in the different periods of pregnancy from preimplantation to embryonic and foetal periods, taking into consideration, among others, the effects on mental development and the carcinogenic risks, are presented.

Diagnostic and therapeutic nuclear medicine procedures in relation to pregnancy are considered.

Patients administered with radiopharmaceuticals normally have family members at home, other persons taking care or giving comfort to the patient and close friends; thus, radiation protection takes into account also the protection of these individuals and in particular of children and pregnant females among them.

In nuclear medicine, the staff members should pay attention in handling radiopharmaceuticals in relation to external and internal exposures, in particular for 131I therapeutic doses. A pregnant or breastfeeding female worker should not work in areas of significant contamination risk.

Keywords

Radiation Protection Pregnant Patient Medical Exposure Prenatal Exposure Female Worker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    ICRP (2000) Pregnancy and medical radiation, ICRP Publication 84. Ann ICRP 30(1)Google Scholar
  2. 2.
    ICRP (2001) Doses to the embryo and fetus from intakes of radionuclides by the mother, ICRP Publication 88. Ann ICRP 31(1–3)Google Scholar
  3. 3.
    ICRP (2003) Biological effects after prenatal irradiation (embryo and fetus), ICRP Publication 90. Ann ICRP 33(1–2)Google Scholar
  4. 4.
    ICRP (2007) Radiological protection, ICRP Publication 105. Ann ICRP 37(6)Google Scholar
  5. 5.
    ICRP (2008) Radiation dose to patients from radiopharmaceuticals – addendum 3 to publication 53, ICRP Publication 106. Ann ICRP 38(1–2)Google Scholar
  6. 6.
    Council of the European Union (1997) Council Directive 97/43 Euratom of 30 June 1997 on health protection of individuals against the dangers of ionising radiation in relation to medical exposures. Off J Eur Commun L-180, 22–27. Luxembourg: Office for the Official Publications of the European CommunitiesGoogle Scholar
  7. 7.
    Commission E (1998) Guidance for protection of unborn children and infants irradiated due to parental medical exposures. Radiation protection 100. Office for the Official Publications of the European Communities, LuxembourgGoogle Scholar
  8. 8.
    Guidance on the application of dose coefficients for the embryo, fetus and breastfed infants in dose assessments for members of the public. Advice from the Health Protection Agency. Documents of the HPA-Radiation, Chemical and Environmental Hazards. RCE-58, March 2000. ISBN 978-0-85951-614-3Google Scholar
  9. 9.
    Protection of pregnant patients during diagnostic medical exposures to ionising radiation. Advice from the Health Protection Agency, the Royal College of Radiologists and the College of Radiographers. Documents of the HPA-Radiation, Chemical and Environmental Hazards. RCE-9, March 2009. ISBN 978-0-85951-635-8Google Scholar
  10. 10.
    Hall EJ (1994) Radiobiology for the radiologist, 4th edn. J.B. Lippincott Co., Philadelphia, PA, USAGoogle Scholar
  11. 11.
    Gu Y, Kai M, Kusama T (1997) The embryonic and fetal effects in ICR mice irradiated in the various stages of the preimplantation period. Radiat Res 147:735–740PubMedCrossRefGoogle Scholar
  12. 12.
    Streffer C, Müller W-U (1996) Malformations after radiation exposure of preimplantation stages. Int J Dev Biol 40:355–360PubMedGoogle Scholar
  13. 13.
    OECD (1988) The biological basis for the control of prenatal irradiation. Report by a Group of Consultants, Paris, FranceGoogle Scholar
  14. 14.
    Konermann G (1982) Consequences of prenatal radiation exposure for perinatal and postnatal development: morphological, biochemical and histochemical aspects. In: Kriegel H, Schmahl W, Kistner G, et al (eds) Developmental effects of prenatal irradiation. Gustav Fischer Verlag, Stuttgart, Germany, pp 237–250Google Scholar
  15. 15.
    Otake M, Schull WJ (1984) In utero exposure to A-bomb radiation and mental retardation. A reassessment. Br J Radiol 57:409–414PubMedCrossRefGoogle Scholar
  16. 16.
    Gilman E, Kneale G, Knox E et al (1988) Pregnancy x-rays and childhood cancers: effects of exposure age and radiation dose. J Radiat Protect 8:3–8CrossRefGoogle Scholar
  17. 17.
    Monson RR, McMahon B (1984) Prenatal x-ray exposure and cancer in children. In: Boice J, Fraumeni J (eds) Radiation carcinogenesis: epidemiology and biological significance. Raven, New York, USA, pp 97–105Google Scholar
  18. 18.
    ICRP (2007) Recommendations of the International Commission on Radiological Protection, ICRP Publication 103. Ann ICRP 37(2–4)Google Scholar
  19. 19.
    Russell JR, Stabin MG, Sparks RB, Watson EE (1997) Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. J Nucl Med 73:756–769Google Scholar
  20. 20.
    Loevinger R, Budinger TF, Watson EE (1991) MIRD primer for absorbed dose calculations. Society of Nuclear Medicine, New York, NYGoogle Scholar
  21. 21.
    Cristy M, Eckerman K (1987) Specific absorbed fractions of energy at various ages from internal photon sources. ORNL/TM-8381 V1–V7. Oak Ridge National Laboratory, Oak Ridge, TNGoogle Scholar
  22. 22.
    Stabin MG, Watson EE, Cristy M et al (1995) Mathematical models and specific absorbed fractions of photon energy in the nonpregnant adult female and at the end of each trimester of pregnancy. ORNL/TM-12907. Oak Ridge National Laboratory, Oak Ridge, TNCrossRefGoogle Scholar
  23. 23.
    Zankl M, Petoussi-Henss N, Fill U, Regulla D (2003) The application of voxel phantoms to the internal dosimetry of radionuclides. Radiat Prot Dosim 105:539–548CrossRefGoogle Scholar
  24. 24.
    Kramer R, Khoury HJ, Vieira JW, Loureiro ECM, Lima VJM, Lima FRA, Hoff G (2004) All about FAX: a female adult voxel phantom for Monte Carlo calculations in radiation protection dosimetry. Phys Med Biol 49:5203–5216PubMedCrossRefGoogle Scholar
  25. 25.
    Petoussi-Henss N, Bolch WE, Zankl M, Sgouros G, Wessels B (2007) Patient-specific scaling of reference S-values for cross-organ radionuclides S-values: what is appropriate? Radiat Prot Dosim 127:192–196CrossRefGoogle Scholar
  26. 26.
    Shi CY, Xu XG, Stabin MG (2008) SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Med Phys 35:3215–3224PubMedCrossRefGoogle Scholar
  27. 27.
    Goo BQ, Xu XG, Shi C (2010) Specific absorbed fractions for internal electron emitters derived for a set of anatomically realistic reference pregnant female models. Radiat Prot Dosim 138(1):20–28CrossRefGoogle Scholar
  28. 28.
    Xu XG (Rensselaer Polytechnic Institute, USA – the consortium of computational human phantoms (CCHP). http://www.virtualphantoms.org/index.html)
  29. 29.
    Watson EE (1992) Radiation absorbed dose to the human foetal thyroid. In: S-Stelson A, Watson EE (eds) 5th international radiopharmaceutical dosimetry symposium, CONF-910529, Oak Ridge Associated Universities, Oak Ridge, TN, USA, p 179–187Google Scholar
  30. 30.
    National Council on Radiation Protection and Measurements NCRP (1998) Radionuclide exposure of the embryo/fetus. Report 128. NCRP, Bethesda. http://www.ncrppublications.org/Reports/128 Google Scholar
  31. 31.
    Berkovski V (1999) Radioiodine biokinetics in the mother and fetus. Part 1. Pregnant woman. In: Radiation and Thyroid Cancer. World Scientific Publishing. Publication No. EUR 18552 EN of the European Commission, pp 319–325Google Scholar
  32. 32.
    Berkovski V (1999b) Radioiodine biokinetics in the mother and fetus. Part 2. Fetus. In: Radiation and Thyroid Cancer. World Scientific Publishing. Publication No. EUR 18552 EN of the European Commission, pp 327–332Google Scholar
  33. 33.
    Anspaugh LR, Napier BA (2009) Minor parameters need for individual dose calculations, PNNL-18917. Pacific Northwest National Laboratory, Richland, WAGoogle Scholar
  34. 34.
    Berg GEB, Nyström EH, Jacobsson L, Lindberg S, Lindstedt RG, Mattsson S, Niklasson CA, Norén AH, Westphal OGA (1998) Radioiodine treatment of hyperthyroidism in a pregnant woman. J Nucl Med 39(2):357–361PubMedGoogle Scholar
  35. 35.
    ICRP (1992) Radiological protection in biomedical research ICRP Publication 62. Ann ICRP 22(3)Google Scholar
  36. 36.
    Ahlgren L, Ivarsson S, Johansson L, Mattsson S, Nosslin B (1985) Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticals. J Nucl Med 26:1085–1090PubMedGoogle Scholar
  37. 37.
    Mountford PJ, Coakle AJ (1989) A review of the secretion of radioactivity in human breast milk: data, quantitative analysis and recommendations. Nucl Med Commun 10(1):15–27PubMedCrossRefGoogle Scholar
  38. 38.
    Stabin MG, Breitz HB (2000) Breast milk excretion of radiopharmaceuticals: mechanisms, findings, and radiation dosimetry. J Nucl Med 41:863–873PubMedGoogle Scholar
  39. 39.
    Safety guide for radiation protection in nuclear medicine. Australian Radiation Protection and Nuclear Safety Agency, Radiation Protection Series Publication No. 14.2, 2008. ISBN 978-0-9805638-0-1, ISSN 1445-9760Google Scholar
  40. 40.
    Treves ST (ed) (2007) Pediatric nuclear medicine/PET, 3rd edn. Heidelberg, Springer. ISBN 038732321XGoogle Scholar
  41. 41.
    Gray L, Torreggiani W, O’Reilly G (2008) Paediatric diagnostic reference levels in nuclear medicine imaging in Ireland. Brit J Radiol 81:918–919PubMedCrossRefGoogle Scholar
  42. 42.
    Ted Treves S, Davis RT, Fahey FH (2008) Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America. J Nucl Med 49:1024–1027PubMedCrossRefGoogle Scholar
  43. 43.
    Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, Dosimetry EANM, Committees P (2007) The new EANM paediatric dosage card. Eur J Nucl Med Mol Imag 34(5):796–798CrossRefGoogle Scholar
  44. 44.
    Lassmann M, Biassoni L, Monsieurs M, Franzius C (2008) EANM dosimetry and paediatrics committees. The New EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imag 35(9):1666–1668CrossRefGoogle Scholar
  45. 45.
    Gelfand MJ, Prisi MT, Ted Treves S (2011) Pediatric radiopharmaceutical administered doses: 2010 North America consensus guidelines. J Nucl Med 52(2):318–322PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of PhysicsUniversità degli Studi di MilanoMilanItaly

Personalised recommendations